Clinical Trial Update: Effect of Diltiazem on Pharmacokinetics of BMS-914392 [Phase 1]

View source ↗

Summary

Phase 1 trial assessing whether diltiazem alters the pharmacokinetics of BMS-914392 in individuals with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• BMS-914392 (BMS-914392)
• Diltiazem (diltiazem)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Atrial Fibrillation | Phase 1 | Status: COMPLETED